Albireo Pharma Inc
ALBO
ALBO was delisted on the 2nd of March, 2023.
29 hedge funds and large institutions have $2.3M invested in Albireo Pharma Inc in 2016 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 5 increasing their positions, 8 reducing their positions, and 5 closing their positions.
12% less funds holding
Funds holding: 33 → 29 (-4)
38% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 8
46% less capital invested
Capital invested by funds: $4.29M → $2.3M (-$1.99M)
80% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$134K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$101K |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$47.1K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$4.89K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$1.55K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$900K |
| 2 |
BC
Broadfin Capital
New York
|
-$685K |
| 3 |
SM
Sabby Management
Miami Beach,
Florida
|
-$333K |
| 4 |
Nomura Holdings
Tokyo,
Japan
|
-$30K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$14.7K |
ALBO Hedge Fund Activity: Q1 2016 in Review
29 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Albireo Pharma Inc (ALBO) for Q1 2016, worth a combined $2.3M — down 46% from $4.29M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of ALBO and 1 opened new positions — a net loss of 4 holders — while 8 trimmed existing stakes and 5 added.
The largest buyer was Renaissance Technologies, adding an estimated $134K. The largest seller was Fidelity Investments, cutting an estimated $900K.
- 29 institutional investors held Albireo Pharma Inc (ALBO) as of Q1 2016, down from 33 in Q4 2015.
- Funds reported $2.3M of Albireo Pharma Inc stock for Q1 2016, down 46% quarter-over-quarter.
- 1 fund opened new Albireo Pharma Inc positions in Q1 2016 and 5 closed out, a net change of -4 holders.
- The largest Albireo Pharma Inc buyer in Q1 2016 was Renaissance Technologies, an estimated $134K added.
- The largest Albireo Pharma Inc seller in Q1 2016 was Fidelity Investments, an estimated $900K sold.
Based on aggregated 13F filings for Q1 2016.